Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2000 1
2002 1
2014 4
2015 6
2016 18
2017 35
2018 36
2019 48
2020 42
2021 41
2022 42
2023 49
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

288 results

Results by year

Filters applied: . Clear all
Page 1
Treatment patterns in women with postmenopausal osteoporosis using abaloparatide: a real-world observational study.
Gold DT, Beckett T, Deal C, James AL, Mohseni M, McMillan A, Bailey T, Pearman L, Caminis J, Wang Y, Williams SA, Kernaghan JM. Gold DT, et al. Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07070-z. Online ahead of print. Osteoporos Int. 2024. PMID: 38653862
This study evaluated real-world treatment patterns for patients new to abaloparatide, regardless of osteoporosis treatment history. METHODS: Data for patients with 1 prescription for abaloparatide were collected retrospectively from six academic and clinical practic …
This study evaluated real-world treatment patterns for patients new to abaloparatide, regardless of osteoporosis treatment history. M …
The cost-effectiveness of osteoporosis medications for preventing periprosthetic fractures following femoral neck fracture indicated hip arthroplasty: a break-even analysis.
Agarwal AR, Kinnard MJ, Murdock C, Zhao AY, Ahiarakwe U, Cohen JS, Moseley KF, Golladay GJ, Thakkar SC. Agarwal AR, et al. Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07085-6. Online ahead of print. Osteoporos Int. 2024. PMID: 38619605
METHODS: Three-year average cost of osteoporosis medication (oral bisphosphonates, estrogen hormonal therapy, intravenous (IV) bisphosphonates, denosumab, teriparatide, and abaloparatide), costs of PPF care, and PPF rates in patients who underwent hip arthroplasty for FNFs …
METHODS: Three-year average cost of osteoporosis medication (oral bisphosphonates, estrogen hormonal therapy, intravenous (IV) bisphosphonat …
Optimal Intermittent Administration Interval of Abaloparatide for Bone Morphogenetic Protein-Induced Bone Formation in a Rat Spinal Fusion Model.
Abe T, Miyazaki M, Sako N, Kanezaki S, Tsubouchi Y, Kaku N. Abe T, et al. Int J Mol Sci. 2024 Mar 25;25(7):3655. doi: 10.3390/ijms25073655. Int J Mol Sci. 2024. PMID: 38612467 Free PMC article.
Both bone morphogenetic protein 2 (BMP-2) and abaloparatide are used to promote bone formation. However, there is no consensus about their optimal administration. We investigated the optimal administration theory for the pairing of BMP-2 and abaloparatide in a rat s …
Both bone morphogenetic protein 2 (BMP-2) and abaloparatide are used to promote bone formation. However, there is no consensus about …
Targeted Delivery of Abaloparatide to Spinal Fusion Site Accelerates Fusion Process in Rats.
Nielsen JJ, Low SA, Chen C, Li X, Mbachu E, Trigg L, Sun S, Tremby M, Hadap R, Low PS. Nielsen JJ, et al. Biomedicines. 2024 Mar 8;12(3):612. doi: 10.3390/biomedicines12030612. Biomedicines. 2024. PMID: 38540225 Free PMC article.
The data presented below demonstrate that subcutaneous administration of a modified abaloparatide conjugated to 20 mer of D-glutamic acid not only localizes at the spinal fusion site but also outperforms the standard of care (topically applied BMP2) in both speed of minera …
The data presented below demonstrate that subcutaneous administration of a modified abaloparatide conjugated to 20 mer of D-glutamic …
An Overlooked Medication-Induced Celiac Flare Complicating Treatment of Osteoporosis.
Phan V, Aurora J Jr, Gondi S, Ceglia L. Phan V, et al. AACE Clin Case Rep. 2024 Jan 11;10(2):60-62. doi: 10.1016/j.aace.2024.01.001. eCollection 2024 Mar-Apr. AACE Clin Case Rep. 2024. PMID: 38523850 Free PMC article.
Given normal serum total alkaline phosphatase (ALP) and parathyroid hormone (PTH), she began treatment of osteoporosis with abaloparatide. Two months later, she reported abrupt onset of diarrhea with significant weight loss. Biochemical investigation revealed a threefold i …
Given normal serum total alkaline phosphatase (ALP) and parathyroid hormone (PTH), she began treatment of osteoporosis with abaloparatide …
Response rates for lumbar spine, total hip, and femoral neck bone mineral density in men treated with abaloparatide: results from the ATOM study.
Dhaliwal R, Kendler D, Saag K, Ing SW, Singer A, Adler RA, Pearman L, Wang Y, Mitlak B. Dhaliwal R, et al. JBMR Plus. 2024 Jan 27;8(2):ziae009. doi: 10.1093/jbmrpl/ziae009. eCollection 2024 Feb. JBMR Plus. 2024. PMID: 38505522 Free PMC article.
In the Abaloparatide for the Treatment of Men With Osteoporosis (ATOM; NCT03512262) trial, 228 men with primary or hypogonadism-associated osteoporosis were randomized to receive subcutaneous injections of abaloparatide 80 mug or placebo. Abaloparatide signif …
In the Abaloparatide for the Treatment of Men With Osteoporosis (ATOM; NCT03512262) trial, 228 men with primary or hypogonadism-assoc …
The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches.
Gupta N, Kanwar N, Arora A, Khatri K, Kanwal A. Gupta N, et al. Clin Rheumatol. 2024 May;43(5):1421-1433. doi: 10.1007/s10067-024-06932-5. Epub 2024 Mar 18. Clin Rheumatol. 2024. PMID: 38499817 Review.
Current pharmacological approaches include anti-osteoporotic drugs such as bisphosphonates, denosumab, teriparatide, abaloparatide, raloxifene, and romosozumab. Conventional disease-modifying antirheumatic drugs such as methotrexate and biologicals including TNF inhibitors …
Current pharmacological approaches include anti-osteoporotic drugs such as bisphosphonates, denosumab, teriparatide, abaloparatide, r …
Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment: a Propensity Score Matched Cohort Study.
Stokar J, Szalat A. Stokar J, et al. J Clin Endocrinol Metab. 2024 Mar 14:dgae173. doi: 10.1210/clinem/dgae173. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38482603
Inclusion criteria were age 40 years, a diagnosis of osteoporosis and prescription of romosozumab or a PTH analog (teriparatide/abaloparatide) during 8.2019-8.2022. 1:1 propensity score matched cohorts were created using demographic variables, comorbidities, and medication …
Inclusion criteria were age 40 years, a diagnosis of osteoporosis and prescription of romosozumab or a PTH analog (teriparatide/abalopara …
Abaloparatide promotes bone repair of vertebral defects in ovariectomized rats by increasing bone formation.
Makino A, Hasegawa T, Yamamoto T, Takagi H, Takahashi Y, Miyakoshi N, Amizuka N. Makino A, et al. Bone. 2024 May;182:117056. doi: 10.1016/j.bone.2024.117056. Epub 2024 Feb 23. Bone. 2024. PMID: 38402920 Free article.
Osteoporotic vertebral fracture (OVF) is the most common type of osteoporotic fracture and is associated with immobility and mortality. Bone anabolic agents, such as abaloparatide (ABL), are usually administered to patients with OVF to prevent subsequent fractures. ...
Osteoporotic vertebral fracture (OVF) is the most common type of osteoporotic fracture and is associated with immobility and mortality. Bone …
288 results